Eptifibatide did not significantly reduce the rate of adverse events in patients undergoing percutaneous coronary revascularization

Research output: Contribution to journalLiterature reviewpeer-review

Original languageEnglish
Pages (from-to)100-1
Number of pages2
JournalEvidence-based Cardiovascular Medicine
Volume1
Issue number4
DOIs
Publication statusPublished - Dec 1997

Cite this